HEADER TRANSFERASE/INHIBITOR 05-JAN-22 7TEU
TITLE CRYSTAL STRUCTURE OF JAK2 JH1 WITH TYPE II INHIBITOR YLIU-04-105-1
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: JANUS KINASE 2,JAK-2;
COMPND 5 EC: 2.7.10.2;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES;
COMPND 8 OTHER_DETAILS: TYROSINE KINASE DOMAIN (JH1)
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: JAK2;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET15B
KEYWDS JAK2, TYROSINE KINASE, INHIBITOR, CYTOKINE SIGNALING, TRANSFERASE,
KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR S.R.HUBBARD
REVDAT 3 25-OCT-23 7TEU 1 REMARK
REVDAT 2 28-JUN-23 7TEU 1 JRNL
REVDAT 1 21-JUN-23 7TEU 0
JRNL AUTH M.L.ARWOOD,Y.LIU,S.K.HARKINS,D.M.WEINSTOCK,L.YANG,
JRNL AUTH 2 K.E.STEVENSON,O.D.PLANA,J.DONG,H.CIRKA,K.L.JONES,
JRNL AUTH 3 A.T.VIRTANEN,D.G.GUPTA,A.CEAS,B.LAWNEY,A.YODA,C.LEAHY,M.HAO,
JRNL AUTH 4 Z.HE,H.G.CHOI,Y.WANG,O.SILVENNOINEN,S.R.HUBBARD,T.ZHANG,
JRNL AUTH 5 N.S.GRAY,L.S.LI
JRNL TITL NEW SCAFFOLDS FOR TYPE II JAK2 INHIBITORS OVERCOME THE
JRNL TITL 2 ACQUIRED G993A RESISTANCE MUTATION.
JRNL REF CELL CHEM BIOL V. 30 618 2023
JRNL REFN ESSN 2451-9456
JRNL PMID 37290440
JRNL DOI 10.1016/J.CHEMBIOL.2023.05.007
REMARK 2
REMARK 2 RESOLUTION. 1.45 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.19.2_4158
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.68
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3
REMARK 3 NUMBER OF REFLECTIONS : 65621
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.194
REMARK 3 R VALUE (WORKING SET) : 0.194
REMARK 3 FREE R VALUE : 0.207
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.040
REMARK 3 FREE R VALUE TEST SET COUNT : 1998
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 28.6800 - 3.4900 0.94 4407 138 0.1819 0.1956
REMARK 3 2 3.4900 - 2.7700 1.00 4595 144 0.1879 0.1994
REMARK 3 3 2.7700 - 2.4200 1.00 4595 144 0.1930 0.2010
REMARK 3 4 2.4200 - 2.2000 1.00 4588 144 0.1881 0.2120
REMARK 3 5 2.2000 - 2.0400 1.00 4588 145 0.1837 0.1995
REMARK 3 6 2.0400 - 1.9200 1.00 4539 142 0.1898 0.1806
REMARK 3 7 1.9200 - 1.8300 1.00 4556 143 0.2082 0.2309
REMARK 3 8 1.8300 - 1.7500 1.00 4593 145 0.2091 0.2271
REMARK 3 9 1.7500 - 1.6800 1.00 4547 143 0.2033 0.2341
REMARK 3 10 1.6800 - 1.6200 1.00 4572 143 0.2043 0.2088
REMARK 3 11 1.6200 - 1.5700 1.00 4568 144 0.2137 0.2344
REMARK 3 12 1.5700 - 1.5300 1.00 4534 142 0.2162 0.2414
REMARK 3 13 1.5300 - 1.4900 1.00 4538 143 0.2207 0.2357
REMARK 3 14 1.4900 - 1.4500 0.96 4403 138 0.2402 0.2444
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.119
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.654
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 14.45
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.82
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.007 2358
REMARK 3 ANGLE : 1.037 3179
REMARK 3 CHIRALITY : 0.087 331
REMARK 3 PLANARITY : 0.008 406
REMARK 3 DIHEDRAL : 9.969 322
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 7TEU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JAN-22.
REMARK 100 THE DEPOSITION ID IS D_1000261755.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 19-MAR-19
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 4
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 19-BM
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.979
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65627
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450
REMARK 200 RESOLUTION RANGE LOW (A) : 28.700
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 200 DATA REDUNDANCY : 4.800
REMARK 200 R MERGE (I) : 0.05000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0
REMARK 200 DATA REDUNDANCY IN SHELL : 3.70
REMARK 200 R MERGE FOR SHELL (I) : 0.33000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.610
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 3UGC
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 51.84
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM POTASSIUM PHOSPHATE MONOBASIC,
REMARK 280 21% (W/V) PEG 3350, PH 4, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.73600
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.67900
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.73600
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.67900
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 HOH A1455 LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 816
REMARK 465 GLY A 817
REMARK 465 SER A 818
REMARK 465 SER A 819
REMARK 465 HIS A 820
REMARK 465 HIS A 821
REMARK 465 HIS A 822
REMARK 465 HIS A 823
REMARK 465 HIS A 824
REMARK 465 HIS A 825
REMARK 465 SER A 826
REMARK 465 SER A 827
REMARK 465 GLY A 828
REMARK 465 LEU A 829
REMARK 465 VAL A 830
REMARK 465 PRO A 831
REMARK 465 ARG A 832
REMARK 465 GLY A 833
REMARK 465 SER A 834
REMARK 465 HIS A 835
REMARK 465 MET A 836
REMARK 465 GLU A 837
REMARK 465 ASP A 838
REMARK 465 ARG A 839
REMARK 465 ASP A 840
REMARK 465 PRO A 841
REMARK 465 THR A 842
REMARK 465 VAL A 1000
REMARK 465 LEU A 1001
REMARK 465 PRO A 1002
REMARK 465 GLN A 1003
REMARK 465 ASP A 1004
REMARK 465 LYS A 1005
REMARK 465 GLU A 1006
REMARK 465 PHE A 1007
REMARK 465 PHE A 1008
REMARK 465 LYS A 1009
REMARK 465 VAL A 1010
REMARK 465 LYS A 1011
REMARK 465 GLU A 1012
REMARK 465 GLY A 1132
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 857 CG CD CE NZ
REMARK 470 GLN A 872 CG CD OE1 NE2
REMARK 470 GLU A 890 CD OE1 OE2
REMARK 470 GLN A 942 CD OE1 NE2
REMARK 470 THR A 998 OG1 CG2
REMARK 470 LYS A 999 CG CD CE NZ
REMARK 470 GLU A1015 CG CD OE1 OE2
REMARK 470 LYS A1053 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 855 -134.27 -103.59
REMARK 500 THR A 875 -154.68 -119.17
REMARK 500 ARG A 975 -32.91 74.84
REMARK 500 ASP A 994 103.15 -163.30
REMARK 500 SER A1054 -8.55 83.18
REMARK 500 ASN A1085 13.89 82.35
REMARK 500
REMARK 500 REMARK: NULL
DBREF 7TEU A 837 1132 UNP O60674 JAK2_HUMAN 837 1132
SEQADV 7TEU MET A 816 UNP O60674 INITIATING METHIONINE
SEQADV 7TEU GLY A 817 UNP O60674 EXPRESSION TAG
SEQADV 7TEU SER A 818 UNP O60674 EXPRESSION TAG
SEQADV 7TEU SER A 819 UNP O60674 EXPRESSION TAG
SEQADV 7TEU HIS A 820 UNP O60674 EXPRESSION TAG
SEQADV 7TEU HIS A 821 UNP O60674 EXPRESSION TAG
SEQADV 7TEU HIS A 822 UNP O60674 EXPRESSION TAG
SEQADV 7TEU HIS A 823 UNP O60674 EXPRESSION TAG
SEQADV 7TEU HIS A 824 UNP O60674 EXPRESSION TAG
SEQADV 7TEU HIS A 825 UNP O60674 EXPRESSION TAG
SEQADV 7TEU SER A 826 UNP O60674 EXPRESSION TAG
SEQADV 7TEU SER A 827 UNP O60674 EXPRESSION TAG
SEQADV 7TEU GLY A 828 UNP O60674 EXPRESSION TAG
SEQADV 7TEU LEU A 829 UNP O60674 EXPRESSION TAG
SEQADV 7TEU VAL A 830 UNP O60674 EXPRESSION TAG
SEQADV 7TEU PRO A 831 UNP O60674 EXPRESSION TAG
SEQADV 7TEU ARG A 832 UNP O60674 EXPRESSION TAG
SEQADV 7TEU GLY A 833 UNP O60674 EXPRESSION TAG
SEQADV 7TEU SER A 834 UNP O60674 EXPRESSION TAG
SEQADV 7TEU HIS A 835 UNP O60674 EXPRESSION TAG
SEQADV 7TEU MET A 836 UNP O60674 EXPRESSION TAG
SEQADV 7TEU PHE A 1007 UNP O60674 TYR 1007 ENGINEERED MUTATION
SEQADV 7TEU PHE A 1008 UNP O60674 TYR 1008 ENGINEERED MUTATION
SEQRES 1 A 317 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY
SEQRES 2 A 317 LEU VAL PRO ARG GLY SER HIS MET GLU ASP ARG ASP PRO
SEQRES 3 A 317 THR GLN PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN
SEQRES 4 A 317 LEU GLY LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG
SEQRES 5 A 317 TYR ASP PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA
SEQRES 6 A 317 VAL LYS LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG
SEQRES 7 A 317 ASP PHE GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN
SEQRES 8 A 317 HIS ASP ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER
SEQRES 9 A 317 ALA GLY ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU
SEQRES 10 A 317 PRO TYR GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS
SEQRES 11 A 317 GLU ARG ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER
SEQRES 12 A 317 GLN ILE CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG
SEQRES 13 A 317 TYR ILE HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL
SEQRES 14 A 317 GLU ASN GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU
SEQRES 15 A 317 THR LYS VAL LEU PRO GLN ASP LYS GLU PHE PHE LYS VAL
SEQRES 16 A 317 LYS GLU PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO
SEQRES 17 A 317 GLU SER LEU THR GLU SER LYS PHE SER VAL ALA SER ASP
SEQRES 18 A 317 VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR
SEQRES 19 A 317 TYR ILE GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET
SEQRES 20 A 317 ARG MET ILE GLY ASN ASP LYS GLN GLY GLN MET ILE VAL
SEQRES 21 A 317 PHE HIS LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU
SEQRES 22 A 317 PRO ARG PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE
SEQRES 23 A 317 MET THR GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO
SEQRES 24 A 317 SER PHE ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG
SEQRES 25 A 317 ASP ASN MET ALA GLY
HET I6C A1201 44
HET GOL A1202 6
HETNAM I6C 3-{(4S)-2-[(CYCLOPROPANECARBONYL)AMINO]IMIDAZO[1,2-
HETNAM 2 I6C B]PYRIDAZIN-6-YL}-N-{3-[(4-ETHYLPIPERAZIN-1-YL)
HETNAM 3 I6C METHYL]-5-(TRIFLUOROMETHYL)PHENYL}-4-METHYLBENZAMIDE
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 I6C C32 H34 F3 N7 O2
FORMUL 3 GOL C3 H8 O3
FORMUL 4 HOH *200(H2 O)
HELIX 1 AA1 GLU A 845 ARG A 847 5 3
HELIX 2 AA2 THR A 888 SER A 904 1 17
HELIX 3 AA3 SER A 936 HIS A 944 1 9
HELIX 4 AA4 LYS A 945 ILE A 948 5 4
HELIX 5 AA5 ASP A 949 LYS A 970 1 22
HELIX 6 AA6 ALA A 978 ARG A 980 5 3
HELIX 7 AA7 SER A 1016 TYR A 1021 5 6
HELIX 8 AA8 ALA A 1022 SER A 1029 1 8
HELIX 9 AA9 SER A 1032 THR A 1049 1 18
HELIX 10 AB1 SER A 1056 GLY A 1066 1 11
HELIX 11 AB2 GLY A 1071 ASN A 1084 1 14
HELIX 12 AB3 PRO A 1095 TRP A 1106 1 12
HELIX 13 AB4 ASN A 1109 ARG A 1113 5 5
HELIX 14 AB5 SER A 1115 ALA A 1131 1 17
SHEET 1 AA1 5 LEU A 849 LYS A 857 0
SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O VAL A 863 N GLY A 856
SHEET 3 AA1 5 GLU A 877 LEU A 884 -1 O VAL A 881 N GLU A 864
SHEET 4 AA1 5 ASN A 924 GLU A 930 -1 O LEU A 927 N LYS A 882
SHEET 5 AA1 5 TYR A 913 SER A 919 -1 N GLY A 915 O ILE A 928
SHEET 1 AA2 2 ILE A 982 ASN A 986 0
SHEET 2 AA2 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983
CRYST1 107.472 69.358 51.509 90.00 99.26 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009305 0.000000 0.001517 0.00000
SCALE2 0.000000 0.014418 0.000000 0.00000
SCALE3 0.000000 0.000000 0.019670 0.00000